GeneOne Life Science, Inc. (KOSE: A011000)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
GeneOne Life Science, Inc. (KOSE: A011000) operates in the Biotechnology industry within the Health Care sector. The company is valued at $31.40M.
trading between 2.60K and 13.43K.
Tweenvest scores GeneOne Life Science, Inc. across four factors: quality 45/100, value 42/100. Its strongest factor is quality.
A011000 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.40M
- Revenue (TTM)
- $7.98M
- P/E
- —
- EPS
- -2,699.67
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- ₩13,425.00
- 52-week low
- ₩2,600.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.13M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kringle Pharma, Inc.TSE: 4884 | $32.60M | ¥614.00 | -4.81% |
| Quince Therapeutics, Inc.NasdaqGS: QNCX | $32.58M | $32.03 | +0.95% |
| GeneBioTech Co. ,LtdKOSDAQ: A086060 | $32.23M | ₩4,990.00 | -1.58% |
| Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.IBSE: ANGEN | $31.63M | TL7.12 | -13.59% |
| Medicure Inc.TSXV: MPH | $31.36M | CA$4.25 | +42.62% |
| Organoidsciences Ltd.KOSDAQ: A476040 | $31.32M | ₩6,340.00 | -7.45% |
| Oncocross Co., Ltd.KOSDAQ: A382150 | $31.31M | ₩3,200.00 | -12.45% |
| Metagenomi Therapeutics, Inc.NasdaqGS: MGX | $30.83M | $0.82 | -1.52% |
Figures last refreshed Oct 18, 2026.